Statement of Ownership (sc 13g)

Date : 07/19/2019 @ 7:06PM
Source : Edgar (US Regulatory)
Stock : Acasti Pharma Inc (ACST)
Quote : 2.04  0.29 (16.57%) @ 4:59AM
After Hours
Last Trade
Last $ 2.00 ▼ -0.04 (-1.96%)

Statement of Ownership (sc 13g)

 

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 13G

(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13D-1(b), (c) AND (d)
AND AMENDMENTS THERETO FILED PURSUANT TO 13D-2(b)

 

                 Acasti Pharma Inc.               
(Name of Issuer)

 

      Common S hares      
(Title of Class of Securities)

 

                          00430K105                            
(CUSIP Number)

 

                      October 23 , 201 8                         
(Date of Event which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

     [   ] Rule 13d-1 (b)
     [ X ] Rule 13d-1 (c)
     [   ] Rule 13d-1 (d)

 

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 

 

 

 

CUSIP No.  00430K105 13G Page 2 of 7 Pages          

 

 

1

 

NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

ACUITAS GROUP HOLDINGS, LLC

 

2

 

C HECK THE APPROPRIATE BOX IF A ME MBER OF A GROUP                                                                                                                                                             (a) [ ]
                                                                                                                                                                          (b) [ ]

 

 

3

 

SEC USE ONLY


 

 

4

 

CITIZENSHIP OR PLACE OF ORGANIZATION
CALIFORNIA

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON

 

5

 

SOLE VOTING POWER
8,650,000  

 

6

 

SHARED VOTING POWER
0

 

7

 

SOLE DISPOSITIVE POWER
8,650,000

 

8

 

SHARE D DISPOSITIVE POWER
0

 

9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

8,650,000

 

10

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES    [   ]


 

 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10 . 5 8 %

 

12

 

TYPE OF REPORTING PERSON
CO

 

 

 

 

 

CUSIP No.  00430K105 13G Page 3 of 7 Pages          

 

 

1

 

NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

Terren S. Peizer

 

2

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP                                                                                                                                                                         (a) [ ]
                                                                                                                                                                                      (b) [ ]

 

 

3

 

SEC USE ONLY
 

 

 

4

 

CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America

 

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON

 

5

 

SOLE VOTING POWER
8,650,000

 

6

 

SHARED VOTING POWER
0

 

7

 

SOLE DISPOSITIVE POWER
8,650,000

 

8

 

SHARE D DISPOSITIVE POWER
0

 

9

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

8,650,000

 

10

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES    [   ]
 

 

11

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10 . 5 8 %

 

12

 

TYPE OF REPORTING PERSON
IN

 

 

 

 

CUSIP No.  00430K105 13G Page 4 of 7 Pages          

 

Item 1(a).     Name of Issuer: Acasti Pharma Inc.

 

Item 1(b).

Address of Issuer's Principal Executive Offices: 545 Promenade du Centropolis, Suite 100, Laval, Quebec, Canada H7T 0A3

 

 

 

Items 2(a), (b) and (c).

Name of Persons Filing, Address of Principal Business Office and Citizenship:

 

This Schedule 13G is being filed on behalf of Acuitas Group Holdings, LLC (“Acuitas”) and Terren S. Peizer, as joint filers (collectively, the "Reporting Persons").

 

The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit A, pursuant to which the Reporting Persons have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended.

 

The principal business office of the Reporting Persons is 2120 Colorado Avenue, #230, Santa Monica, California 90404. For citizenship, see Item 4 of each cover page.

 

Item 2(d).          Title of Class of Securities: Common Shares

 

Item 2(e).          CUSIP Number: 00430K105

 

Item 3.              Not Applicable

 

Item 4.             Ownership:     

 

(a)     Amount Beneficially Owned: Amount beneficially owned: 8,650,000 shares which includes (i) 5,000,000 common shares held by Acuitas and (ii) 3,650,000 common shares issuable upon the exercise of currently exercisable warrants held by Acuitas.

 

(b)     Percent of Class: 10.58%, based on 78,132,734 common shares outstanding as of March 31, 2019

 

(c)     Number of shares as to which such person has:

 

(i)     sole power to vote or to direct the vote: 8.650,000

 

(ii)     shared power to vote or to direct the vote: 8,650,000

 

(iii)     sole power to dispose or to direct the disposition of: 8,650,000

 

(iv)     shared power to dispose or to direct the disposition of: 8,650,000

 

 

 

 

CUSIP No.  00430K105 13G Page 5 of 7 Pages          

        

 

Item 5. Ownership of Five Percent or Less of a Class: Not Applicable
   

Item 6.

Ownership of More than Five Percent on Behalf of Another Person: Not Applicable

 

Item 7.

Identification and Classification of Subsidiary Which Acquired the Securities: Not Applicable

   
Item 8. Identification and Classification of Members of the Group: Not Applicable
   
Item 9. Notice of Dissolution of Group: Not Applicable
   
Item 10. Certification: Not Applicable

 

 

 

          

CUSIP No.  00430K105 13G Page 6 of 7 Pages          

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated:     July 19, 2019     

 

 

 

ACUITAS GROUP HOLDINGS, LLC

 

 

 

 

 

 

By:

/s/ Terren S. Peizer

 

 

Name: Terren S. Peizer

 

  Title: Managing Member  

 

 

 

 

       
  /s/ Terren S. Peizer  
  Name: Terren S. Peizer  

 

 

 

 

    Page 7 of 7 Pages          

 

EXHIBIT A

 

AGREEMENT REGARDING JOINT FILING

OF STATEMENT ON SCHEDULE 13D OR 13G

 

The undersigned agree to file jointly with the Securities and Exchange Commission (the "SEC") any and all statements on Schedule 13D or Schedule 13G (and any amendments or supplements thereto) required under section 13(d) of the Securities Exchange Act of 1934, as amended, in connection with purchases and sales by the undersigned of the securities of Acasti Pharma Inc.. until such time as the undersigned file with the SEC a statement terminating this Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G.  

 

 

Dated: July 19, 2019

 

 

 

ACUITAS GROUP HOLDINGS, LLC

 

 

 

 

 

 

By:

/s/ Terren S. Peizer

 

 

Name: Terren S. Peizer

 

  Title: Managing Member  
     
     
  /s/ Terren S. Peizer  
  Name: Terren S. Peizer  

 

 

 

 

 

Acasti Pharma (NASDAQ:ACST)
Historical Stock Chart

1 Year : From Dec 2018 to Dec 2019

Click Here for more Acasti Pharma Charts.

Acasti Pharma (NASDAQ:ACST)
Intraday Stock Chart

Today : Saturday 14 December 2019

Click Here for more Acasti Pharma Charts.

Latest ACST Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.